single molecule array Quanterix Raises $73.7M in IPO The firm sold more than 4.9 million shares of common stock at $15 per share, raising $73.7 million to expand its commercial operations and grow its technology. Quanterix Plans IPO The firm plans to use the proceeds to expands its commercial operations, expand its existing technology, and support the launch of its new platform. Quanterix Completes $8.5M Private Placement The funding was led by T. Rowe Price and will be used by Quanterix to develop new instruments, expand the firm's assay menu, and other things. Quanterix Invests in ImmunArray, Gains Access to Brain Injury Biomarker Portfolio ImmunArray will use Quanterix's Simoa single-molecule array technology for biomarker analysis, with the potential to enrich its diagnostic panels. Quanterix Licenses Traumatic Brain Injury Assays From Banyan Biomarkers The company will develop the assays for its single-molecule array technology and incorporate the markers into multiplex assays for research use in neurology. Mar 23, 2016 Quanterix Raises $46M in Series D Financing Feb 16, 2016 New Study Shows Single-Cell Proteomic Possibilities for Quanterix's Simoa Technology Premium Jan 27, 2016 Quanterix Inks Distribution Deals in Asia Pacific Region Nov 6, 2015 Quanterix Upgrades Simoa Platform, Ups Multiplexing Capabilities Premium Jul 23, 2015 Quanterix Lands $500K NFL Head Injury Grant Jun 17, 2015 Quanterix Names PBL Preferred Partner Jun 3, 2015 U of Illinois Scientists Discover How TALENs Find Their Way Around the Genome Mar 5, 2015 Myriad Partners with Quanterix on Assay Services Feb 4, 2015 Formerly Twistnostics, Scanogen Looks to Develop First MDx Test for TB Premium Oct 7, 2014 Twistnostics Using Phase II NIH Grant to Develop Circulating DNA Mutation Assay Premium Sep 3, 2013 Swedish Researchers Adopt Quanterix Arrays to Identify Concussion Biomarkers in Hockey Players Premium Aug 2, 2013 New Products: Quanterix Launches Simoa Instrument and More Premium Nov 30, 2012 BioMerieux Takes $15M Stake in Quanterix, Gains Exclusive Global License to SiMoA as IVD Platform Premium Nov 15, 2012 BioMerieux Invests $15M in Quanterix as Part of Test Development Partnership Oct 12, 2012 Quanterix Study Suggests Simoa Platform Can Compete with Nucleic Acid-Based HIV Tests Premium Jul 24, 2012 Quanterix Building Commercial Team Ahead of Planned 2013 Launch for Simoa Platform Premium Feb 10, 2012 Forsyth Wins Gates Foundation Grant for TB Biomarker Work on Quanterix's SiMoA System Premium Feb 9, 2012 Forsyth, Quanterix, and Beth Israel to Collaborate on TB Test Jan 10, 2012 In-Q-Tel Backs Quanterix to Expand Pathogen Detection for Defense Applications Premium Jan 6, 2012 With Backing from In-Q-Tel, Quanterix Continues Move into Pathogen Detection, Defense Applications Premium Load More Breaking News Lander, Collins Offer Vision for Advanced Research Projects Agency for Health LetsGetChecked Partners With California Department of Public Health for COVID-19 Sequencing BTIG Initiates Coverage of Berkeley Lights With Buy Rating Quest Diagnostics to Offer Biocept's Target Selector NGS Lung Cancer Test Novacyt 2020 Revenues Surge on Strong Demand for SARS-CoV-2 Testing Products Leidos Wins CDC Bioinformatics Contract Worth up to $13M The Scan Could Cost Billions NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars. Not Quite Sent The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post. DTC Regulation Proposals A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports. PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.